First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
Titel:
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
Auteur:
Wicki, Andreas Brown, Nicholas Xyrafas, Alexandros Bize, Vincent Hawle, Hanne Berardi, Simona Cmiljanović, Nataša Cmiljanović, Vladimir Stumm, Michael Dimitrijević, Saša Herrmann, Richard Prêtre, Vincent Ritschard, Reto Tzankov, Alexandar Hess, Viviane Childs, Alexa Hierro, Cinta Rodon, Jordi Hess, Dagmar Joerger, Markus von Moos, Roger Sessa, Cristiana Kristeleit, Rebecca